Universitätsklinikum Frankfurt am Main (KGU)

A prospective survey study on the education and awareness about walking exercise amongst inpatients with symptomatic peripheral arterial disease in Germany (2023) Li Y, Rother U, Rosenberg Y, Hinterseher I, Uhl C, Mylonas S, Grambow E, et al. Journal article Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial (2023) Koehm M, Rossmanith T, Foldenauer AC, Herrmann E, Brandt-Jürgens J, Burmester GR, Kellner H, et al. Journal article Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 (2023) Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C, Reinhardt HC, Aguiar E, et al. Journal article Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz (2023) Leipe J, Schmelz R, Riemekasten G, Thaçi D, Henes J, Schäkel K, Pinter A, et al. Journal article Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma (2023) Scheiner B, Roessler D, Phen S, Lim M, Pomej K, Pressiani T, Cammarota A, et al. Journal article Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland (2022) Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akcetin L, et al. Journal article Author Correction: Relationship between different serum cartilage biomarkers in the acute response to running and jumping in healthy male individuals (Scientific Reports, (2022), 12, 1, (6434), 10.1038/s41598-022-10310-z) (2022) Dreiner M, Munk T, Zaucke F, Liphardt AM, Niehoff A Journal article, Erratum Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas (2022) Bunse L, Rupp AK, Poschke I, Bunse T, Lindner K, Wick A, Blobner J, et al. Journal article Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (2022) Petter E, Scheibenbogen C, Linz P, Stehning C, Wirth K, Kuehne T, Kelm M Journal article